Physician profile
Tyler Scott
NPI 1053872812
$7,509.95
in general payments reported to CMS, 2019-2025
10 companies · $1,885 in 2025
The $1,885 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,748 · 2023: $155 · 2024: $721 · 2025: $1,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,963 · Travel and Lodging: $538 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,962.80 |
| Travel and Lodging | $538.20 |
| Education | $261.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,446.89 | 2022-2025 | Mako, Axsos, Gamma |
| Gemini Mountain Medical, LLC | $2,400.00 | 2022 | |
| Medacta USA, INC. | $629.87 | 2024-2025 | Gmk Sphere, Gmk Revision |
| Medical Device Business Services, INC. | $261.00 | 2025 | Actis |
| Depuy Synthes Sales INC. | $235.98 | 2025 | Na, Va-Lcp |
| Microport Orthopedics INC | $194.00 | 2025 | Mpo Medial Pivot Knee |
| Cerapedics INC. | $155.40 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Heron Therapeutics, INC. | $125.00 | 2025 | Zynrelef |
| Skeletal Dynamics INC | $41.82 | 2024 | Implate, Align, Geminus |
| Glaxosmithkline, LLC. | $19.99 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.